Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Adrenogenital syndrome
ADR ID BADD_A08575
ADR Hierarchy
03      Congenital, familial and genetic disorders
03.09      Endocrine disorders congenital
03.09.02      Adrenal disorders congenital
03.09.02.001      Adrenogenital syndrome
05      Endocrine disorders
05.01      Adrenal gland disorders
05.01.02      Adrenal cortical hypofunctions
05.01.02.004      Adrenogenital syndrome
21      Reproductive system and breast disorders
21.03      Sexual function and fertility disorders
21.03.02      Sexual function and fertility disorders NEC
21.03.02.015      Adrenogenital syndrome
Description Abnormal SEX DIFFERENTIATION or congenital DISORDERS OF SEX DEVELOPMENT caused by abnormal levels of steroid hormones expressed by the GONADS or the ADRENAL GLANDS, such as in CONGENITAL ADRENAL HYPERPLASIA and ADRENAL CORTEX NEOPLASMS. Due to abnormal steroid biosynthesis, clinical features include VIRILISM in females; FEMINIZATION in males; or precocious sexual development in children. [MeSH]
MedDRA Code 10061630
MeSH ID D047808; D000312; D047808
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Adrenal virilism | Adrenogenital disorders | Adrenogenital syndrome congenital | Adrenogenital syndrome NOS | Congenital adrenal hyperplasia | Congenital adrenal hyperplasia - sodium losing form | Congenital adrenal hyperplasia - virilising form | Adrenogenital syndrome | Androgenital syndrome | Adrenogenital Syndrome | Adrenogenital Syndromes | Syndrome, Adrenogenital | Syndromes, Adrenogenital
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Growth hormone receptorP16882Not Available
Receptor protein-tyrosine kinaseQ6QHH2Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00615Desloratadine0.002643%
BADD_D00623Dexamethasone0.004806%
BADD_D01617Ondansetron0.000150%
The 1th Page    1    Total 1 Pages